Aligos Therapeutics (ALGS) News Today → the most reliable asset on earth is making a comeback (From DTI) (Ad) Free ALGS Stock Alerts $0.98 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studiesglobenewswire.com - March 27 at 8:00 AMAligos Therapeutics Inc (ALGS)uk.investing.com - March 16 at 10:34 PMMaintaining a Hold: Balancing Promise and Risk in Aligos Therapeutics’ Clinical Pipelinemarkets.businessinsider.com - March 15 at 5:07 AMAligos Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - March 14 at 9:04 AMRecap: Aligos Therapeutics Q4 Earningsbenzinga.com - March 12 at 7:05 PMAligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Resultsmarkets.businessinsider.com - March 12 at 7:05 PMAligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 12 at 4:05 PMPiper Sandler Reaffirms Their Buy Rating on Aligos Therapeutics (ALGS)markets.businessinsider.com - March 8 at 1:06 PMTracking Baker Brothers Portfolio - Q4 2023 Updateseekingalpha.com - March 6 at 6:12 PMAligos Therapeutics (ALGS) Set to Announce Earnings on Tuesdaymarketbeat.com - March 6 at 9:14 AMAligos Therapeutics to Announce 4th Quarter 2023 Financial Results on March 12, 2024globenewswire.com - March 5 at 4:05 PMAligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024globenewswire.com - February 26 at 8:00 AMAligos Therapeutics (ALGS) Price Target Increased by 300.00% to 4.08msn.com - February 24 at 1:30 PMAligos Therapeutics Stock (NASDAQ:ALGS) Earnings Dates and Earning Callsbenzinga.com - February 23 at 3:51 PMAligos Therapeutics Stock (NASDAQ:ALGS), Short Interest Reportbenzinga.com - February 23 at 3:51 PMAligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024finance.yahoo.com - February 20 at 9:18 AMAligos Therapeutics to Host KOL Event to Discuss Phase 2a HERALD Study of ALG-055009 in MASH on March 7, 2024globenewswire.com - February 20 at 8:00 AMAligos Therapeutics, Inc. (ALGS)finance.yahoo.com - February 19 at 1:33 PMAligos Therapeutics bolsters executive team with new VPsinvesting.com - February 15 at 10:25 PMAligos Therapeutics Strengthens Finance Leadership Team with Two New Appointmentsfinance.yahoo.com - February 13 at 8:46 AMAligos Therapeutics in portfolio reorganization focused on NASH, COVID assetsmsn.com - February 10 at 7:33 AMLeerink Partnrs Comments on Aligos Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:ALGS)marketbeat.com - February 7 at 9:09 AMAligos Therapeutics Launches Voluntary Option Exchange Programmsn.com - January 26 at 9:31 PMAligos Therapeutics Inc Ordinary Sharesmorningstar.com - January 5 at 10:07 PMIs Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?finance.yahoo.com - January 5 at 12:06 PMAligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)finance.yahoo.com - December 7 at 5:53 PMAligos Therapeutics To Present at the Piper Sandler Healthcare Conferencefinance.yahoo.com - November 20 at 9:04 PMAligos Therapeutics files to sell 168.73M shares of common stockmsn.com - November 17 at 7:22 PMAligos Therapeutics Presents Clinical and Nonclinical Data at the AASLD Liver Meeting® 2023 Demonstrating that ALG-055009 has a Favorable Risk-Benefit Profilefinance.yahoo.com - November 13 at 10:37 AMAligos Therapeutics Presents Positive Data at the AASLD Liver Meeting® 2023 Demonstrating that Treatment with ALG-000184 (CAM-E) Results in Significant Multi-log Reductions in Hepatitis B Antigens (HBsAg, HBcrAg and HBeAg)finance.yahoo.com - November 10 at 12:39 PMAligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Datafinance.yahoo.com - November 3 at 5:35 PMAligos Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Resultsmarkets.businessinsider.com - November 2 at 8:46 PMAligos Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 2 at 8:46 PMAligos Therapeutics Inc (ALGS) Reports Q3 2023 Financial Results and Business Progressfinance.yahoo.com - November 2 at 8:46 PMEarnings Outlook For Aligos Therapeuticsbenzinga.com - November 1 at 5:48 PMAligos Therapeutics to Announce 3rd Quarter Results on November 2, 2023finance.yahoo.com - October 26 at 6:49 PMAligos Therapeutics To Present Late Breaking Poster on ALG-000184, its CAM-E Drug Candidate, at The Liver Meeting® 2023finance.yahoo.com - October 25 at 9:21 AMWhy Aligos Therapeutics (ALGS) Stock Is Nosedivingbenzinga.com - October 23 at 7:12 PMAligos Therapeutics Shares Hit All-Time Low After Private Placementmarketwatch.com - October 23 at 2:11 PMAligos Therapeutics Announces $92 Million Private Placement Financingfinance.yahoo.com - October 23 at 9:11 AMAligos Therapeutics Announces Award of an $8.5 Million NIAID Contract to Advance Development of Best-In-Class Pan-Coronavirus Protease Inhibitor, ALG-097558finance.yahoo.com - October 3 at 8:10 AMAligos Therapeutics Announces IND Clearance for NASH lead, ALG-055009finance.yahoo.com - September 21 at 8:14 AMAligos Therapeutics (NASDAQ: ALGS)fool.com - August 20 at 8:46 PMAligos Therapeutics GAAP EPS of -$0.43 beats by $0.06, revenue of $2.59Mmsn.com - August 3 at 8:00 PMAligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 3 at 8:00 PMAligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 3 at 8:00 PMAligos Therapeutics to Announce Second Quarter Results on August 03, 2023finance.yahoo.com - July 28 at 10:12 AMAligos Therapeutics Announces the Selection of Stephen Harrison, MD as Principal Investigator of Ph2a Study and Key Study Design Elements/Milestones for NASH Drug Candidate, ALG-055009finance.yahoo.com - July 19 at 8:12 AMAligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023finance.yahoo.com - June 21 at 6:52 PMAligos Therapeutics to Present Data on its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023it.tmcnet.com - June 7 at 11:00 AM Get Aligos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now ALGS Media Mentions By Week ALGS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALGS News Sentiment▼0.960.61▲Average Medical News Sentiment ALGS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALGS Articles This Week▼21▲ALGS Articles Average Week Get Aligos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ALGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Elutia News Today Assembly Biosciences News Today Instil Bio News Today Cognition Therapeutics News Today Semper Paratus Acquisition News Today Passage Bio News Today Genenta Science News Today AlloVir News Today Atara Biotherapeutics News Today Ikena Oncology News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALGS) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aligos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.